Taiwan Advance Bio-Pharmaceutical Inc operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Taiwan Advance Bio-Pharmaceutical Inc with three other
companies in this sector in TAIWAN :
Holy Stone Healthcare Co Ltd
sales of 204.16 million Taiwanese Dollars [US$6.95 million]
(305.69 million Taiwanese Dollars [US$10.41 million]
of which 100%
was Pharmaceutical Development), and
General Biological Corporation
(239.65 million Taiwanese Dollars [US$8.16 million]
During the year ended December of 2019, sales at
Taiwan Advance Bio-Pharmaceutical Inc were 205.80 million Taiwanese Dollars (US$7.01 million).
increase of 22.2%
versus 2018, when the company's sales were 168.35 million Taiwanese Dollars .
This was the third consecutive year of growth at Taiwan Advance Bio-Pharmaceutical Inc.